Bendamustine and Its Role in the Treatment of Unfit Patients With Chronic Lymphocytic Leukaemia: A Perspective Review

Therapeutic Advances in Hematology- United States

doi 10.1177/2040620717699365

Full Text

Abstract

Available in

Categories

Hematology

Date

Authors

Publisher

SAGE Publications

Related search

The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology

Klinicka Onkologie
Oncology
2020English

Chronic Lymphocytic Leukaemia

Nature Reviews Disease Primers
Medicine
2017English

Thiamine Deficiency in Patients With B-Chronic Lymphocytic Leukaemia: A Pilot Study

Postgraduate Medical Journal
Medicine
2001English

Prognostic Role of Translocator Protein and Oxidative Stress Markers in Chronic Lymphocytic Leukemia Patients Treated With Bendamustine Plus Rituximab

Oncology Letters
Cancer ResearchOncology
2014English

Treatment Options for High-Risk Chronic Lymphocytic Leukaemia

Therapeutic Advances in Hematology
Hematology
2011English

Chronic Lymphocytic Leukaemia: The Role of T Cells in a B Cell Disease

British Journal of Haematology
Hematology
2019English

Stomach Cancer in a Patient With Chronic Lymphocytic Leukaemia

Creative surgery and oncology
2019English

Tumour Lysis Syndrome After Treatment of Chronic Lymphocytic Leukaemia With Fludarabine.

Postgraduate Medical Journal
Medicine
1994English

Efficancy of Rituximab With Chlorambucil Regimen in Elderly Patients With Chronic Lymphocytic Leukaemia

Hematology & blood transfusion: interdepartamental collection
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy